STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race
09:23 EST 7 Dec 2017 |
STAT
Roche reported that its Tecentriq immunotherapy drug slowed progression of lung cancer and helped patients live longer in a late-stage study.
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race
NEXT ARTICLE
More From BioPortfolio on "STAT Plus: Pharmalittle: Retail drug spending growth slows; Roche looks to leapfrog in lung cancer race"